Relationship between Clinicopathological Features and Expression of COX-2 among Colorectal Cancer Patients: A Prospective Observational Study
Abstract
Colorectal cancer (CRC) is the third most common cancer globally and a leading cause of cancer-related mortality. Cyclooxygenase-2 (COX-2) plays a critical role in CRC pathogenesis by promoting inflammation, tumor proliferation, and metastasis. COX-2 inhibitors, such as NSAIDs, have shown potential in reducing CRC progression. However, the relationship between COX-2 expression and clinicopathological features remains controversial. This study aims to assess the correlation between COX-2 expression and clinicopathological characteristics in CRC patients in Indonesia. A prospective observational study was conducted on 81 CRC patients at a tertiary hospital in West Java, Indonesia, from January to June 2024. COX-2 expression was quantified using qPCR from tumor tissue samples. Clinicopathological data, including age, sex, tumor grade, stage, and complications, were collected and analyzed. Among the 81 participants, 81.5% were over 50 years old. Low-grade adenocarcinoma was the most prevalent histopathological type (73%), followed by high-grade adenocarcinoma (11%) and mucinous adenocarcinoma (11%). The majority of cases were in regional or early stages (74%), while 26% were in late stages. Higher COX-2 expression was more frequent in males, rectal tumors, high- grade adenocarcinomas, advanced stages, and metastatic cases. Although no statistically significant association was found, a trend toward increased COX-2 expression in advanced CRC was observed. No significant association was found between COX-2 expression and clinicopathologic characteristics of CRC. However, higher COX-2 expression may be associated with advanced disease.
Keyword: Clinicopathological features, Colorectal cancer, Cyclooxygenase-2, Inflammation, Metastasis
Full Text:
PDFReferences
Cercek, A., Chatila, W. K., Yaeger, R., Walch, H., Dos, G., Fernandes, S., Krishnan, A., Palmaira, L., Maio, A., Srinivasan, P., Bandlamudi, C., Salo-mullen, E., Segal, N., Tejada, P. R., Belanfanti, K., Galle, J., Joseph, V., Varghese, A., Reidy-lagunes, D., … Stadler, Z. K. (2021). A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. Journal of the National Cancer Institute, 113(12), 1683–1692. https://doi.org/10.1093/jnci/djab124
Cuschieri, S. (2019). The STROBE guidelines. Saudi Journal of Anesthesia, 13(1), 31–34. https://doi.org/10.4103/sja.SJA
Durand-onaylı, V., Haslauer, T., Härzschel, A., & Hartmann, T. N. (2018). Rac GTPases in Hematological Malignancies. International Journal of Molecular Sciences, 19, 1–24. https://doi.org/10.3390/ijms19124041
Elm, E. Von, Altman, D. G., Peter, C. G., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2022). Improving Reporting of Observational Studies in Epidemiology (STROBE): Clarification and Refinement. Вопросы Современной Педиатрии, 21(3), 173–207. https://doi.org/10.17816/DD70821.
Georgiou, A., Khakoo, S., Edwards, P., Minchom, A., Kouvelakis, K., Kalaitzaki, E., Nobar, N., Calamai, V., Ifijen, M., Husson, O., Watkins, D., Rao, S., Chau, I., & Cunningham, D. (2019). Outcomes of Patients with Early Onset Colorectal Cancer Treated in a UK Specialist Cancer Center. Cancers, 11(10), 1–15.
Gök, M. A., Kafadar, M. T., & Yeğen, S. F. (2021). Perforated colorectal cancers : clinical outcomes of 18 patients who underwent emergency surgery. Gastroenterology Review, 16(2), 161–165. https://doi.org/https://doi.org/10.5114/pg.2021.106667
Goradel, N. H. (2018). Cyclooxygenase ‐ 2 in cancer : A review. Journal of Cellular Physiology, 234(5), 1–17. https://doi.org/10.1002/jcp.27411
Gupta, S. C., Kim, J. H., Prasad, S., & Aggarwal, B. B. (2011). Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer and Metastasis Reviews, 29(3), 405–434. https://doi.org/10.1007/s10555-010-9235-2.Regulation
Han, B., Zheng, R., Zeng, H., Wang, S., Sun, K., Chen, R., Li, L., Wei, W., & He, J. (2024). Journal of the National Cancer Center Cancer incidence and mortality in China , 2022 ✩. Journal of the National Cancer Center, 4(January), 47–53. https://doi.org/10.1016/j.jncc.2024.01.006
He, K., Wang, Z., Luo, M., Li, B., Ding, N., Li, L., He, B., Wang, H., & Cao, J. (2023). Metastasis organotropism in colorectal cancer : advancing toward innovative therapies. Journal of Translational Medicine, 21(612), 1–23.
Hu, Y., Li, W., Cheng, X., Yang, H., She, Z., Cai, J., Li, H., & Zhang, X. (2024). Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases. Circulation Research, 135(1), 222–260. https://doi.org/10.1161/CIRCRESAHA.124.324383
Ibrahim, N. I., Shamsudin, S. H., Lee, S. K., Emilia, S., & Sharif, T. (2023). Human Pathology Reports Prognostic significance of Cyclooxygenase-2 expression in colorectal adenoma and Adenocarcinoma : A clinicopathologic study. Human Pathology Reports, 31(March), 1–9. https://doi.org/https://doi.org/10.1016/j.hpr.2023.300692
Indratama, I. M. B., Made, N., Anggreni, R., Ade, L., & Andriyani, G. (2024). Profile of Colorectal Cancer Patients Undergoing Chemotherapy at RSU Grha Bhakti Medika Klungkung in 2023-2024. Intisari Sains Medis, 15(3), 1100–1105. https://doi.org/10.15562/ism.v15i3.2152
Kasi, A., Handa, S., Bhatti, S., Umar, S., Bansal, A., & Sun, W. (2021). Molecular Pathogenesis and Classification of Colorectal Carcinoma. HHS Public Access, 16(5), 97–106. https://doi.org/10.1007/s11888-020-00458-z
Kolawole, O. R., & Kashfi, K. (2022). NSAIDs and Cancer Resolution : New Paradigms beyond Cyclooxygenase. International Journal of Molecular Sciences, 23(3), 1–32. https://doi.org/https://doi.org/10.3390/ijms23031432
Kulesza, A., Paczek, L., & Hoffman, F. (2023). The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells. Biomedicines, 11(2), 1–21. https://doi.org/10.3390/biomedicines11020445
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & Depinho, R. A. (2021). Genetic and biological hallmarks of colorectal cancer. https://doi.org/10.1101/gad.348226.120.GENES
Low, E. E., Demb, J., Liu, L., & Earles, A. (2021). Risk Factors for Early-Onset Colorectal Cancer. Gastroenterology, 159(2), 492–501. https://doi.org/10.1053/j.gastro.2020.01.004.Risk
Meester, R. G. S., Mannalithara, A., Lansdorp-Vogelaar, I., & Ladabaum, U. (2019). Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years , 1975-2015. Jama, 321(19). https://doi.org/10.1001/jama.2019.3076
Miller, K. D., Sauer, A. G., & Fedewa, S. A. (2020). Colorectal Cancer Statistics , 2020. American Cancer Society, 70(3), 145–164. https://doi.org/10.3322/caac.21601
Mizuno, R., Kawada, K., & Sakai, Y. (2019). Prostaglandin E2 / EP Signaling in the Tumor Microenvironment of Colorectal Cancer oxygen species. International Journal of Mo, 20(24).
Nasry, W. H. S., Rodriguez-lecompte, J. C., & Martin, C. K. (2018). Role of COX-2/PGE2 Mediated Inflammation in Oral Squamous Cell Carcinoma. Cancers, 10(10), 1–21. https://doi.org/10.3390/cancers10100348
Negi, R. K. V. and D. S. (2020). The Development of COX-1 and COX-2 Inhibitors: A Review. International Journal of Pharmaceutical Sciences and Research, 11(8), 3544–3555. https://doi.org/10.13040/IJPSR.0975-8232.11(8).3544-55
Negi, R. R., Rana, S. V., Gupta, V., Gupta, R., Dani, V., Prasad, K. K., & Dhawan, D. K. (2019). Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients. Asian Pacific Journal of Cancer Prevention, 20(6), 1675–1681. https://doi.org/10.31557/APJCP.2019.20.6.1675
Nigam, M., Prakash, A., Kumar, V., Bandhu, D., Tiwari, V., Gabriela, S., Florina, A., & Radu, A. (2023). Biomedicine & Pharmacotherapy Evaluation of the association of chronic inflammation and cancer : Insights and implications. Biomedicine & Pharmacotherapy, 164(June), 1–27. https://doi.org/10.1016/j.biopha.2023.115015
Norel, X., Sugimoto, Y., Ozen, G., Abdelazeem, H., Amgoud, Y., Bouhadoun, A., Bassiouni, W., Goepp, M., & Mani, S. (2025). Differences and similarities between human and rodents concerning prostaglandin EP1-4 and IP receptors : Specific roles in pathophysiologic conditions International Union. International Union of Basic and Clinical Pharmacology, 910–968. https://doi.org/10.1124/pr.120.019331
Oi, I., Wong, L., Lam, Y. T., Lam, K. F., Cowling, B. J., & Leung, G. M. (2021). Demographic and Epidemiological Contributions to Recent Trends in Cancer Incidence in Hong Kong. Cancers, 13(22), 1–11.
Parmar, S., & Easwaran, H. (2022). Genetic and epigenetic dependencies in colorectal cancer development. Gastroenterology Report, 10(March), 1–17. https://doi.org/10.1093/gastro/goac035
Perez, S., & Eisenstein, S. (2024). Cancer in Anal Fistulas. Clinics in Colon and Rectal Surgery, 37(1), 41–45. https://doi.org/10.1055/s-0043-1762928
Punganuru, S. R., Madala, H. R., & Mikelis, C. M. (2018). Conception , synthesis , and characterization of a rofecoxib- combretastatin hybrid drug with potent cyclooxygenase-2 ( COX-2 ) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models. Oncotarget, 9(40), 26109–26129.
Purnama, A., Lukman, K., Rudiman, R., Prasetyo, D., Fuadah, Y., Nugraha, P., & Siulinda, V. (2023). The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer : A systematic review and meta analysis. Heliyon, 9(September), 1–9.
Rashid, G., Khan, N. A., Elsori, D., Rehman, A., Tanzeelah, Ahmad, H., Maryam, H., Rais, A., Usmani, M. S., Babker, A. M., Kamal, M. A., & Hafez, W. (2023). drugs and biomarkers : A new paradigm in colorectal cancer. Pathology, 10(March), 1–21. https://doi.org/10.3389/fmed.2023.1130710
Rebuzzi, F., Ulivi, P., & Tedaldi, G. (2023). Genetic Predisposition to Colorectal Cancer: How Many and Which Genes to Test? International Journal of Molecular Sciences, 24(3), 1–23. https://doi.org/https://doi.org/10.3390/ijms24032137
Rudiman, R., Subspbd, K., Wijaya, A., Subspbd, K., Sribudiani, Y., Soedjana, H. S., Subspel, K., & Wiraswati, H. L. (2023). Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study. Annals of Medicine & Surgery, 85(5), 1761–1768. https://doi.org/https://doi.org/10.1097/ms9.0000000000000694
Sarasqueta, C., Perales, A., Escobar, A., Baré, M., Redondo, M., Larrea, N. F. De, Briones, E., & Piera, J. M. (2019). Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer : patients with stage III colon or stage II / III rectal cancer. BMC Cancer, 19, 1–15.
Stamatakis, K., Jime, M., Hidalgo-este, A. M., & Lo, R. (2020). Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal Cancer. Frontiers in Pharmacology, 11(April), 1–13. https://doi.org/10.3389/fphar.2020.00533
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
Wu, X., Lin, H., & Li, S. (2019). Prognoses of different pathological subtypes of colorectal cancer at different stages : A population-based retrospective cohort study. BMC Gastroenterology, 19, 1–8.
Yan, S., Zhan, F., He, Y., Zhu, Y., & Ma, Z. (2025). p53 in colorectal cancer : from a master player to a privileged therapy target. Journal of Translational Medicine. https://doi.org/10.1186/s12967-025-06566-4
Yang, Z., Wang, X., Zhou, H., Jiang, M., Wang, J., & Sui, B. (2024). Molecular Complexity of Colorectal Cancer : Strategies Molecular Complexity of Colorectal Cancer : Pathways , Biomarkers , and Therapeutic Strategies. Cancer Management and Research, 16, 1389–1402. https://doi.org/10.2147/CMAR.S481656
Yoo, H. J., Kim, T. J., Kim, D. J., & Kim, W. (2020). Role of COX2 as a Biomarker for Estimating Survival of Patients With Clinical Stage I Gastric Cancer. Anticancer Research, 40, 341–347. https://doi.org/10.21873/anticanres.13958
Yu, X., Wu, H., Wu, B., Zhi, S., Lan, Y., Chen, W., & Liu, J. (2025). Advances and challenges in drug repurposing in precision therapeutics of colorectal cancer. World Journal of Gastrointestinal Oncology, 17(7), 1–18. https://doi.org/10.4251/wjgo.v17.i7.107681
Zhang, Q., Dong, G., Wang, F., & Ding, W. (2020). Correlation between the changes of serum COX 2 , APE1 , VEGF , TGF ‑ β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. Journal of Cancer Research and Therapeutics, 16(2), 335–342. https://doi.org/10.4103/jcrt.JCRT
Zhou, S., Zhao, Z., Wang, Z., Xu, H., Li, Y., Xu, K., & Li, W. (2025). Cancer-associated fibroblasts in carcinogenesis. Journal of Translational Medicine, 23(50), 1–14.
(5), 536–542.
DOI: http://dx.doi.org/10.30829/contagion.v7i3.24233
Refbacks
- There are currently no refbacks.
Copyright (c) 2026 Mohamad Romdhoni, Kiki Lukman, Reno Rudiman, Andriana Purnama, Bambang Am Am Setya Sulthana Degrees, Tommy Ruchimat, Alma Wijaya, Yunia Sribudiani Degrees, Prapanca Nugraha
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
